VK

Veena Kumari

Active Director Director DIN 05148841
DIN 05148841 First appointment Jan 2012 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2012
Shareholding value •••• Premium profile

About Veena Kumari

Data last updated:

Veena Kumari is a Director at Amvissa Pharmaceuticals Private Limited (since 2012). The company operates in Healthcare. Amvissa Pharmaceuticals Private Limited reported revenue of ₹5 Lakh (FY 2017).

DIN 05148841
Primary Designation Director
Industry Healthcare
First Appointment 04 Jan 2012
Oldest Company Age 14 yrs
Largest company Amvissa Pharmaceuticals Private Limited · ₹5 Lakh (FY 2017)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director04 Jan 20122012₹5 Lakh (FY 2017)Active

Board colleagues of Veena Kumari

NameDINCompanyDesignation
Vinay Krishna05148849Amvissa Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Amvissa Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Veena Kumari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Veena Kumari

Veena Kumari currently holds 1 directorship: Amvissa Pharmaceuticals Private Limited (Director, since 04 Jan 2012, revenue ₹5 Lakh (FY 2017)).

Veena Kumari was first appointed on 04 Jan 2012 as Director at Amvissa Pharmaceuticals Private Limited.

The current boards of Veena Kumari's companies include Vinay Krishna (Amvissa Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available